Russian high-tech pharmaceutical enterprises: reasons and factors for sustainable innovation Online publication date: Fri, 01-Apr-2016
by Karina A. Alenina; Dolores S. Bengoa; Yuliya Vlasova
J. for Global Business Advancement (JGBA), Vol. 9, No. 2, 2016
Abstract: Global challenges, such as the high speed of the business internationalisation process, strong competition, natural environment or economic powers, are setting high standards for the pharmaceutical sector. For achieving this competitive sustainability, companies have to provide the best of their human capital and technological resources to reach great innovation levels. The paper explores reasons and motives that positively influence the innovative capacity and the potential for innovation in the Russian pharmaceutical market. The case study targeted a population of 100 subjects. Stratified and simple random sampling techniques are used to select a sample size of 50 respondents using questionnaires for data collection. Data are analysed through descriptive statistics and presented in frequency tables, graphs and computed percentages. The researchers recommend that management should minimise employee turnover to increase the skills of the employees, hiring staff should be done based on academic qualifications, and monetary and non-monetary resources should be allocated evenly for innovation purposes.
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.Complimentary Subscribers, Editors or Members of the Editorial Board of the J. for Global Business Advancement (JGBA):
Login with your Inderscience username and password:
Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.
If you still need assistance, please email subs@inderscience.com